PALI-2108 for colitis, ulcerative

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Aug 2026: Trial started, NCT07845487
  2. 29 Sep 2026: Trial registered, NCT07845487

The trials

NCT07845487: A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

State
Under way
Phase
Phase 2
People
204 planned
Started
28 Aug 2026
Primary completion
Oct 2027
Arms
PALI-2108 Dose 1, PALI-2108 Dose 2
Results
None posted
  1. 28 Aug 2026: Trial started
  2. 29 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.